Certara, Inc. · NASDAQ:CERT
Certara — Fact Sheet (November 2025)
4 slides from Certara's fact sheet, November 2025
Slide 1: Streamline Your Drug Discovery Process
Streamline Your Drug Discovery Process Digitalizing Your Workflows in the Design-Make-Test-Analyze Cycle Increasing efficiency in the drug discovery process is an important factor in increasing the success rate of drug development in later stages. Maximize your investment in operational excellence wit
Slide 2: Software to improve drug discovery
Software to improve drug discovery Our discovery focus Compound Lead Preclinical Target ID Hit to Lead Clinical Trials Screening Optimization Development • Review of • Virtual and • Property Prediction • In vitro competitive high-throughput and in vivo • DMTA Cycles landscape screening studies • Str
Slide 3: Close the DMTA informatics loop
Close the DMTA informatics loop Move seamlessly from data through queries, integrated analysis and Design and Analysis Products knowledge and design all the way visualization let discovery teams • D360 to realization. Our solutions give understand their data and focus • Design Hub you a simple way t
Slide 4: About Certara
ome t e to c Quo “D360 is saving us hundreds of hours annually on data analysis. That is an important contribution to our research. The Certara team is tenacious and resourceful. They always find a solution. That’s what has made our relationship so successful.” Dr. Keith Hornberger, Director of Chem
Certara — Fact Sheet (November 2025) on 6ix